CVS Health Corporation
CVS Health 2024 Annual Meeting: Stockholder Approvals and Incentive Plan Amendments
Summary
On May 16, 2024, CVS Health Corporation held its 2024 Annual Meeting of Stockholders, where all 12 nominees for director were elected to the Company's Board of Directors. Stockholders approved the ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for 2024, the advisory approval of the compensation of the Company's named executive officers, and amendments to the 2017 Incentive Compensation Plan, which increase the number of common shares of the Company available for issuance under the Plan by 33.5 million shares. Four stockholder proposals were not approved.
Profitelligence Alerts
Get alerts for CVS
Be first to know when CVS Health Corporation files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About CVS Health Corporation
CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.
Official SEC Documents
Advertisement